We used a monoclonal antibody against GP II b-IIIa complex (NNKY1-32) to study the relationship between platelet aggregation and the condition of GP II b-III a complex in unstimulated and some factors in plsma appears to be necessary condition.
Introduction
Platelet GP If b and GP 111 a are said to be major constituents of the plaelet membrane that are critically involved in the formation of the cell surface fibrinogen receptor on activated platelets', 2) . More recently, it has been reported that the GP II b and GP JU a exist predominantly as the Ca2+-dependent, heterodimer complex, and incubation of intact platelets with ethylenediamine tetraacetic acid (EDTA) at 37°C causes progressive dissociation of GP IfI b-III a complexes3-5) . The binding of GP I I b/ III a to fibrinogen becomes apparent only after stimulation of platelets with an agonist such as ADP or thrombin6, 7) . Agonists may induce a conformational change directly within GP II b/ III a so as to render it a competent receptor, or cause changes in the microenvironment so that a hidden receptor becomes accessible to macromolecular ligands8, 9) . The conformational change of GP II b/ III a in stimulated platelets appears thus to be influenced not only by the quantity of GP II b-III a complexes on the unstimulated platelets but also by the associated condition of the "complex" and its microenvironment. In this study, we investigated the relationship between platelet aggregability and GP II b-lIIa complex in the platelets with various GP I I b-IIIa complexes quantitatively and qualitatively using flow cytometry 11)
Materials and Methods
Monoclonal antibodies : Monoclonal anti-GP II b-1 a complex antibody (NNKY1-32) was used.
This antibody was described previously4, 1113)• Glanzmann's thrombasthenia (GT) 14 ' 15) and Heterozygote : Type I GT ; 39-year-old woman.
Platelet count was normal, bleeding time prolonged, and clot retraction abnormal. Platelet aggregation induced by ADP, collagen, epinephrine and thrombin were defective or declined extremely. Type II GT ; 44-year-old woman. Platelet count was normal, bleeding time prolonged, but clot retraction normal. Platelet aggregation was the same as Type I GT.
Heterozygote ; 33-year-old woman, younger sister of the Type I GT patient. Platelet count, bleeding time and platelet aggregation were almost normal.
Incubation of intact platelets with EDTA : Washed platelets were resuspended to a platelet count of 3 x 108/a, and incubated with EDTA-phosphate buffered saline (PBS) ( ) (containing Change of platelet aggregation : Samples were classified into three groups by the fluorescence Table 1 Platelet aggregation in GT, Heterozygote, EDTA-treated and cation-treated platelets.
Platelet aggregation is expressed as the ratio (mean±SD) of the maximum aggregation of the sample platelets to that of the control platelets . *1 : EDTA-treated platelets (2 mM, 37°C, 10 min) were incubated with cation-free Tyrode's buffer for 60 min at 37°C. *2 : EDTA-treated platelets were incubated with auto-plasma for 60 min at S -38 intensity of NNKY1-32, and their aggregabilities are shown in Table 1 . ADP-and thrombininduced aggregation were defective or declined markedly in GT (Tyepe I , Type II ) , but retained in Heterozygote platelets. On the other hand, in intact platelets incubated with EDTA at 37°C, ADP-aggregability declined more rapidly than the quantity of GP I b/ Ill a complex, while thrombin-aggregability was much better maintained. ADP-and thrombin-induced aggregations were observed in Ca2+, Mg2+, auto-plasma or mixed materials (Mg2++Ca2+ + autoplasma) treated platelets. But differences were found in ADP-aggregability among these samples. When washed platelets were incubated with EDTA at 37°C for 10 min and with cation free Tyrode's buffer at 37°C for 60 min, the fluorescence intensity of anti-GP b-Ill a complex antibody decreased to about 10% of that of control platelets. In these platelets the quantities of GP II b and GP f a were normal, while the quantity of "complex" was markedly decreased, as in Type I and Type I GT. These platelets, classified as group I, underwent the slight thrombin-induced aggregation but did not undergo ADP-induced aggregation. It was speculated that the quantity of GP II b-lU a complex in the unstimulated platelets was below the level needed for fibrinogen-mediated aggregation to be induced when platelets are stimulated.
Discussion
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When EDTA-treated platelets were incubated with auto-plasma, the fluorescence intensity of anti-GP I b-lila complex antibody was about 60% of that of control platelets, about the same as that of platelets incubated with EDTA at 37°C for 10 min. This is the interesting result. Because it is speculated that the concentration of cations in auto-plasma is insufficient for the reassociation of GP I b-III a complex. In the previous5) and this studies, we reported that Ca2+ (2 mM) and Mg2+ (2 mM) promoted the reassociation of dissociated GP I b and GP fa in intact cells. Moreover, recently, we confirmed the reassociation of GP I b-I a complex by cation using immunoelectron microscopy' 6) . It appears to need the same concentration of cations as in vivo to promote the reassociation of GP 11 b-III a complex.
When EDTA-treated platelets were incubated with Tyrode's buffer containing Ca2+, Mg2+ or mixed materials (Ca2+ + Mg2+ + auto-plasma) , the fluorescence intensity of anti-GP I b-I a complex antibody was about 80% that of control platelets. This quantity of GP 11 b-III a complex was almost as same as that of platelets incubated with EDTA at 37°C for 5 min and of the Heterozygote platelets which used this study. ADP-and thrombin-induced aggregation was observed under these conditions, the latter stronger than the former. Differences in both aggregabilities were also observed between samples (EDTA treatment, cation treatment and Heterozygote) . Particularly, there existed the marked discrepancy in ADP-induced aggregation.
ADP-aggregability of Ca2 + or Mg2 treated platelets was stronger than that of platelets incubated with EDTA at 37°C for 5 min. And ADP-aggregability of the mixed materials treated platelets and the Heterozygote platelets were stronger than that of Ca2 + or Mg2 + treated platelets. This result explains the "quantitative" as well as "qualitative" importance of GP bEl a complex in unstimulated platelets. It was speculated that these quantities of GP II bcomplexes could be aggregated by ADP, but that if GP 11 b and GP lila were merely associated, the conformational change of GP I bAl a was difficult of induction by ADP. Perhaps it is important that quality of GP II b-Of a complex, the microenvironment around "complex" or some factor in plasma.
In this study, the discrepancy was observed between thrombin-induced aggregation and the The qualitative importance of GP I b-III a complex has been reported previously. A variant of GT28) , acquired GT29) and functional GT30) appeared to be caused by abnormality of GP b/ID a itself, autoanti-platelet antibody and drug metabolites, respectively. In all these cases, GP II a complex was normal quantitatively. Therefore, it is speculated that both quantitative and qualitative factors concerning the GP I b-I a complex of unstimulated platelets are important for the conformational change of GP I b/ DI a in the activated platelets by ADP.
